---
title: "Pharscin Pharma: Injectable Sulbactam-Nafcillin has received drug re-registration approval"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263234216.md"
description: "Pharscin Pharma announced that it recently received the \"Drug Re-registration Approval Notice\" for its product, injectable sulbactam-natamycin, issued by the Chongqing Municipal Drug Administration. The drug approval number is valid until October 22, 2030. The re-registration of this product is approved. Since this product has not been produced for a long time, before resuming production, the holder must complete the relevant work according to the requirements of related documents and submit a resumption application to the Municipal Drug Administration. After on-site inspection and passing the quality check of a batch of products, and subsequent two batches of products passing inspection, it can be marketed for sale"
datetime: "2025-10-29T08:06:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263234216.md)
  - [en](https://longbridge.com/en/news/263234216.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263234216.md)
---

# Pharscin Pharma: Injectable Sulbactam-Nafcillin has received drug re-registration approval

Pharscin Pharma announced that it recently received the "Drug Re-registration Approval Notice" for its product, injectable sulbactam-natamycin, issued by the Chongqing Municipal Drug Administration. The drug approval number is valid until October 22, 2030. The re-registration of this product is approved. Since this product has not been produced for a long time, before resuming production, the holder must complete the relevant work according to the requirements of related documents and submit a resumption application to the municipal drug administration. After on-site inspection and passing the quality check of a batch of products, and subsequent two batches of products passing inspection, it can be marketed and sold

### Related Stocks

- [002907.CN](https://longbridge.com/en/quote/002907.CN.md)

## Related News & Research

- [Cramer reiterates debt-coverage rule amid high-rate pressures](https://longbridge.com/en/news/287048552.md)
- [11:05 ETThe Church of Jesus Christ of Latter-day Saints Commits $25 Million to the UNICEF-led Child Nutrition Fund](https://longbridge.com/en/news/287088476.md)
- [Ganfeng Lithium starts small-scale production of 500 Wh/kg solid-state batteries](https://longbridge.com/en/news/287152551.md)
- [RUBBER-Japan futures fall on rising supply prospects, weak demand](https://longbridge.com/en/news/287175409.md)
- [AI|China’s Ganfeng secures orders amid surge in demand for energy storage, AI boom](https://longbridge.com/en/news/286895092.md)